HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
Asia Biotech Live
LATEST UPDATES » Vol 24, No 01, January 2020 – Empowering the Patient - Personalization of Diabetes Management       » First of its kind Human Heart-in-a-Jar Model for therapeutic solutions       » China's National Vaccine Tracking System set to be completed in 2020       » China's amended drug administration law kicks in       » Human activity puts Chinese plant biodiversity at risk, study finds       » Contributory effects of each brain cell type in development of Alzheimer's Disease      
EYE ON CHINA
BGI Partners with NRGene to Provide Broadest Genomic Analysis Available

Ness Ziona, Israel, and Shenzhen, China, August 15, 2016 – BGI, the world’s largest omics organisation, announced today that it will be offering NRGene’s technology as part of its broad genomics analysis services in agriculture research.

BGI supports genomic research worldwide by offering a variety of genetic research and application technologies for the healthcare, agriculture, conservation, and environmental fields. It also publishes the respected international research journal, GigaScience, to further contribute to the genomics community.

NRGene provides genomic assessment and assembly tools that solve the most complex genomic challenges accurately and rapidly. Most recently, NRGene mapped the bread and pasta wheat genomes, which represent the most complex genomes to assemble, in mere weeks rather than years.

“We have recognised the complementary capabilities that NRGene’s and BGI’s technologies provide to the Chinese genomics community, with its wide and diverse challenges,” said Gao Qiang, CEO of BGI Tech. “The combined technologies will transform Asian agriculture.”

NRGene’s DeNovoMAGICTM 2.0 delivers the most accurate reference genomes fast and cost effectively, while PanMAGICTM provides genome-to-genome mapping across varieties. It displays all types of sequence differences and structural variations within the studied genetic material including SNPs, InDels of any size, inversions, translocations, gene PAVs, and gene CNVs.

“Being a selected technology by the world’s leading omics group is a major step forward as we continue to disrupt the genomics industry,” said Dr. Gil Ronen, CEO, NRGene. “Our high quality genomic analysis is already advancing agricultural genomics, and this will help drive us into other markets that are primed to accelerate their research.”

Source: NRGene & K2 Global Comms

Click here for the complete issue.

NEWS CRUNCH  
news Joining Forces to Elevate Asia's Healthcare Industry
news 4th Global Feed Summit draws Feed Producers, Technology Providers, Raw Materials Suppliers to Bangkok for Key Discussions
news 2nd China Pharma Digital Innovation Summit to be held in Shanghai
news 2nd China Healthcare Digital Innovation Summit to be held in Shanghai
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy